EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation

Zhang Lin, Meilian Yao, Xin Xu, Dong Zhang, Lei Xu, Ling Rong, Xiaohang Wang, Yi Duan, Chengkun Chen, Jun Gu, Yao Zhang, Qiang Liu und 4 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202507524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Zhang Lin und 15 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Sh…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Amphiregulin, Radiation Tolerance, Esophageal Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, State Key Laboratory of Oncogenes and Related Gene, Scientific and Technological Research and Talent Cultivation Project of Renji Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neoadjuvant chemoradiotherapy (nCRT) improves outcomes for locally advanced esophageal squamous cell carcinoma (ESCC) but exhibits variable efficacy due to heterogeneous radiosensitivity. In this study, metabolic profiling of 59 ESCC patients revealed significant alterations in tricarboxylic acid cycle (TCA) cycle intermediates in pathological complete responders (pCR) vs. non‐responders (non‐pCR) ESCC patients after nCRT. Functional experiments demonstrated that radioresistant ESCC cells (KYSE410R) exhibited elevated OXPHOS activity, which is reversed by targeting TCA cycle enzymes (CPI‐613 (Devimistat), fumarate hydratase‐IN‐1 (FH‐IN‐1), etc.) or Oxidative phosphorylation (OXPHOS) inhibitors (IACS‐010759, Rotenone, etc.). Irradiation‐induced CCAAT Enhancer Binding Protein Beta (CEBPB) upregulated AREG/EREG expression, activating the ERBB/mTOR pathway to promote OXPHOS flux. Knockdown of CEBPB/AREG/EREG disrupted OXPHOS and sensitized ESCC cells to radiation. Clinically, high Amphiregulin/Epiregulin (AREG/EREG) levels correlated with nCRT resistance and poor prognosis. Collectively, the CEBPB/AREG/EREG axis drives radioresistance by reprogramming OXPHOS, suggesting inhibition of this pathway or OXPHOS itself as a promising strategy to enhance ESCC therapeutic responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaAmphiregulinRadiation ToleranceEsophageal NeoplasmsOxidative PhosphorylationEpiregulinHumansCell Line, TumorMaleFemaleMiddle AgedChemoradiotherapyCCAAT-Enhancer-Binding Protein-beta

Stichwörter der Autor:innen

AREGCEBPBEREGOXPHOSesophageal squamous cell carcinomaneoadjuvant chemoradiotherapy

Substanzen

AmphiregulinEpiregulinCEBPB protein, humanCCAAT-Enhancer-Binding Protein-beta

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China.
  • Department of Radiation Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Pathology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
  • Department of Thoracic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.

ORCID-Profile: Gaoping Cui, Yujun Hao

Förderung

  • National Natural Science Foundation of China
  • State Key Laboratory of Oncogenes and Related Gene
  • Scientific and Technological Research and Talent Cultivation Project of Renji Hospital
  • Science and Technology Commission of Shanghai Municipality
  • Incubating Program for Clinical Innovation of Renji Hospital
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  • Shanghai Municipal Health and Family Planning Commission

Zitieren

APA

Lin, Z., Yao, M., Xu, X., Zhang, D., Xu, L., Rong, L., Wang, X., Duan, Y., Chen, C., Gu, J., Zhang, Y., Liu, Q., Ye, Q., Cui, G., Hao, Y., & Ma, X. (2026). Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation. Advanced Science. https://doi.org/10.1002/advs.202507524

Vancouver

Lin Z, Yao M, Xu X, Zhang D, Xu L, Rong L, et al. Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation. Advanced Science. 2026. doi:10.1002/advs.202507524

BibTeX
@article{Lin2026,
  author = {Lin, Zhang and Yao, Meilian and Xu, Xin and Zhang, Dong and Xu, Lei and Rong, Ling and Wang, Xiaohang and Duan, Yi and Chen, Chengkun and Gu, Jun and Zhang, Yao and Liu, Qiang and Ye, Qing and Cui, Gaoping and Hao, Yujun and Ma, Xiumei},
  title = {Amphiregulin and Epiregulin Confer Radioresistance in Esophageal Squamous Cell Carcinoma Through Oxidative Phosphorylation},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202507524}
}
Kostenlos starten →